首页> 外文期刊>European journal of clinical nutrition >The metabolic fate of doubly labelled lactose-(13C, 15N)ureide after pre-dosing with different ureides.
【24h】

The metabolic fate of doubly labelled lactose-(13C, 15N)ureide after pre-dosing with different ureides.

机译:用不同的脲类化合物预先加药后,双标记的乳糖-(13C,15N)脲类化合物的代谢命运。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: To date, the measurement of the orocaecal transit time (OCTT) with lactose-[(13)C]ureide usually requires a pre-dosing with the analogous substrate in its unlabelled form. OBJECTIVE: In this study, the enzyme induction provoked by different unlabelled sugar ureides in OCTT measurements when using doubly labelled lactose-[(13)C, (15)N]ureide (DLLU) was evaluated. METHODS: Thirteen healthy adults (age: 22-58 years) received 500 mg DLLU together with a standardized breakfast. Expired air, urine and faeces were collected over a period of 14, 48 and 72 h, respectively. After 1 and 2 weeks, the test was repeated after pre-dosing of 3 x 120 mg glucose ureide (GU) and 3 x 200 mg cellobiose ureide (CU), respectively, on the day before study begin. The (13)C- and (15)N-enrichments were measured by isotope ratio mass spectrometry. The OCTT was calculated by the detection of a significant (13)CO(2) increase. RESULTS: In comparison with the period without pre-dosing (7.8+/-2.2 h), the measured OCTT was significantly lowered either after GU pre-dosing (5.8+/-1.9 h, P=0.033) or CU pre-dosing (6.0+/-2.2 h, P=0.039). The respective renal (13)C- and (15)N-excretions amounted to 24.5 and 45.6, 24.7 and 54.0, and 22.5 and 50.1%, respectively, whereas the faecal (13)C- and (15)N-excretions amounted to 12.1 and 45.8, 4.8 and 21.5, and 9.6 and 39.8%, respectively. CONCLUSIONS: Pre-dosing with unlabelled GU and CU before the administration of DLLU led to an unequivocal induction of the enzyme activity and resulted in a definitive estimation of the OCTT, clearly demonstrating that glucose-[(13)C]ureide is the matrix of the bacterial degradation in the caecum.
机译:背景:迄今为止,使用乳糖[[(13)C]脲]对口经时间(OCTT)的测量通常需要以未标记形式的类似底物进行预加药。目的:本研究评估了使用双标记乳糖-[(13)C,(15)N]脲(DLLU)时,OCTT测量中不同的未标记糖脲引起的酶诱导作用。方法:十三位健康的成年人(年龄在22-58岁之间)接受了500 mg DLLU以及标准早餐。分别在14、48和72小时内收集过期的空气,尿液和粪便。 1周和2周后,分别在开始研究的前一天分别预灌3 x 120 mg葡萄糖酰脲(GU)和3 x 200 mg纤维二糖酰脲(CU)后重复测试。通过同位素比质谱法测量(13)C-和(15)N-富集。通过检测到显着(13)CO(2)增加来计算OCTT。结果:与未预先给药的时间段(7.8 +/- 2.2 h)相比,GU预先给药(5.8 +/- 1.9 h,P = 0.033)或CU预先给药后,测得的OCTT显着降低( 6.0 +/- 2.2小时,P = 0.039)。肾脏(13)C-和(15)N的排泄分别为24.5%和45.6、24.7和54.0、22.5和50.1%,而粪便(13)C-和(15)N的排泄分别为分别为12.1和45.8、4.8和21.5,以及9.6和39.8%。结论:在给予DLLU之前预先给予未标记的GU和CU会导致酶活性的明确诱导,并导致对OCTT的明确估计,这清楚地证明了葡萄糖[[(13)C] ureide是葡萄糖的基质盲肠中的细菌降解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号